|
Report ID
|
168941 |
|
Drug Identification Number
|
02238830 |
|
Brand name
|
CLAVULIN 400 |
|
Common or Proper name
|
amoxicillin / clavulanate potassium for oral suspension |
|
Company Name
|
GLAXOSMITHKLINE INC |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
AMOXICILLIN
CLAVULANIC ACID |
|
Strength(s)
|
400MG
57MG |
|
Dosage form(s)
|
POWDER FOR SUSPENSION |
|
Route of administration
|
ORAL
ORAL |
|
Packaging size
|
70ML |
|
ATC code
|
J01CR |
|
ATC description
|
BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
|
Reason for shortage
|
Demand increase for the drug. |
|
Anticipated start date
|
|
|
Actual start date
|
2022-09-05 |
|
Estimated end date
|
2023-03-31 |
|
Actual end date
|
2023-03-15 |
|
Shortage status
|
Resolved |
|
Updated date
|
2024-02-14 |
|
Company comments
|
Inventory on allocation to support demand. For emergency supply, contact GSK Customer Service 1-800-387-7374. |
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
1-800-387-7374 |
